ARCHIVES

FDA News: FDA Approves Reagent System for Graft-Versus-Host Disease

This article is from The Cancer Letter archive.

Vol. 40 No. 04 | January 24, 2014

Download PDF Visit The Full Archive

Related Articles

Phase III Study: Lymphoseek Superior to Vital Blue Dye

June 24, 2011

Variation in Breast Density May Be Strong Risk Factor

July 27, 2012

Trial Tests Selenium, Vitamin E In Prostate Cancer Prevention.

July 27, 2001

Dana-Farber And Merck To Collaborate On Therapeutics.

February 15, 2008

ODAC Nixes Sanofi’s VTE Drug in 14-1 Vote, Setting High Bar For Adjunctive Therapies

June 22, 2012

Advisors Approve $50 Million NCI Effort To Attack Cancer On a Molecular Level

July 2, 1999